CreativeOne Wealth’s Neurogene NGNE Stock Holding History

CreativeOne Wealth’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-525	Closed	-$97K	–	722
2021 Q2	$97K	Hold	525	–	–	0.01%	663
2021 Q1	$129K	Buy	+525	New	+$134K	0.01%	549

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

CreativeOne Wealth's NGNE Position: Q3 2021 in Review

CreativeOne Wealth sold out of Neurogene (NGNE) in Q3 2021, closing a stake of 525 shares — an estimated $97K sold.

CreativeOne Wealth first reported a position in NGNE in Q1 2021 and held it in 2 quarters. The position peaked at $129K in Q1 2021. 85 funds tracked by Wall St. Rank hold NGNE as of Q3 2021.

CreativeOne Wealth reported no remaining Neurogene position as of Q3 2021 after selling out during the quarter.
CreativeOne Wealth sold 525 Neurogene shares in Q3 2021, an estimated $97K.
CreativeOne Wealth first reported a position in Neurogene in Q1 2021 and held it in 2 quarters.
CreativeOne Wealth's Neurogene position peaked at $129K in Q1 2021.
85 funds tracked by Wall St. Rank held Neurogene as of Q3 2021.

Based on CreativeOne Wealth's 13F filing for Q3 2021, filed 16 Nov 2021.